Teva Announces Launch of Generic Epzicom® Tablets in the United States
Teva Pharmaceutical Industries Ltd announced the launch of a generic equivalent of Epzicom®1 (abacavir and...
Gilead Sciences and the World Health Organization Announce Five-Year Visceral Leishmaniasis Collaboration
Gilead Sciences Inc announced it has entered into a partnership with the World Health Organization...
Vital to Showcase Enterprise Interoperability for Improved Clinical Care and Business Intelligence at HIMSS...
Vital Images, Inc. a Minneapolis-based advanced medical imaging and informatics company, will feature its enterprise...
RRC Introducing The next-generation in chemical-free moisture analysis Computrac Vapor Pro XL
Arizona Instrument LLC is proud to announce the release of the Computrac® Vapor Pro® XL...
FDA Approves Troxyca ER Capsules with Abuse-Deterrent Properties for the Management of Pain
Pfizer Inc announced that the U.S. Food and Drug Administration (FDA) has approved Troxyca ER...
AstraZeneca provides update on Phase III trial of Selumetinib in non-small cell lung cancer
AstraZeneca announced results from the Phase III SELECT-1 trial of the MEK 1/2 inhibitor,...
Biogen Announces Bioverativ as Name of New Hemophilia-Focused Company
Biogen announced that Bioverativ will be the name of the standalone, publicly-traded global biotechnology company...
Takeda Receives Marketing Authorization in Canada for NINLARO™ (ixazomib) in Relapsed/Refractory Multiple Myeloma
Takeda Pharmaceutical Company Limited announced Takeda Canada has received approval from Health Canada for NINLARO™...
FDA Approves Mercks KEYTRUDA® for Patients with Recurrent or Metastatic Head and Neck Cancer
Merck known as MSD outside the United States and Canada, announced that the U.S. Food...
Teva Announces Launch of Generic Gleevec® Tablets in the United States
Teva Pharmaceutical Industries Ltd announced the launch of the generic equivalent to Gleevec®1(imatinib mesylate) tablets,100...